2020
DOI: 10.3390/ma13173714
|View full text |Cite
|
Sign up to set email alerts
|

Polydopamine Linking Substrate for AMPs: Characterisation and Stability on Ti6Al4V

Abstract: Infections are common complications in joint replacement surgeries. Eradicated infections can lead to implant failure. In this paper, analogues of the peptide KR-12 derived from the human cathelicidin LL-37 were designed, synthesised, and characterised. The designed antimicrobial peptides (AMPs) were attached to the surface of a titanium alloy, Ti6Al4V, by conjugation to a polydopamine linking substrate. The topography of the polydopamine coating was evaluated by electron microscopy and coating thickness measu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0

Year Published

2021
2021
2025
2025

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 16 publications
(11 citation statements)
references
References 47 publications
0
8
0
Order By: Relevance
“…Lastly, human osteosarcoma cells were cultivated on the metal plates and beside the ones modified with KR-12/32-5911, the cells attached densely on all other surfaces, they were viable and able to proliferate. Based on their results, the authors claimed the potential of the herein presented antimicrobial metallic surfaces that were modified with KR12, KR12/32, or KR12-5911, respectively, for application as biomedical materials [35]. However, additional strategies to circumvent the observed toxicity of AMPs have to be developed.…”
Section: Secondary Coating-two Step Approach Including Linker Layersmentioning
confidence: 97%
“…Lastly, human osteosarcoma cells were cultivated on the metal plates and beside the ones modified with KR-12/32-5911, the cells attached densely on all other surfaces, they were viable and able to proliferate. Based on their results, the authors claimed the potential of the herein presented antimicrobial metallic surfaces that were modified with KR12, KR12/32, or KR12-5911, respectively, for application as biomedical materials [35]. However, additional strategies to circumvent the observed toxicity of AMPs have to be developed.…”
Section: Secondary Coating-two Step Approach Including Linker Layersmentioning
confidence: 97%
“…Specifically, because the quinine and catechol groups of Frontiers in Bioengineering and Biotechnology frontiersin.org polydopamine can create a chelated structure with the material through a series of chemical reactions, it has broad adhesion properties and can adhere to almost any surface. The mechanism by which polydopamine coatings can be used to load bioactive factors such as AMPs lies in the fact that such amine-containing nucleophilic reagents can be coupled to pDAs via Schiff base reactions or Michael addition reactions of benzoquinone groups under weak alkaline conditions, leading to secondary modification (Trzcińska et al, 2020). The advantages of the polydopamine coating strategy are low cost, ease of handling, wide application and optimized biocompatibility.…”
Section: Surface Immobilizationmentioning
confidence: 99%
“…The advantages of the polydopamine coating strategy are low cost, ease of handling, wide application and optimized biocompatibility. So this strategy is also widely used in AMPs delivery system ( He S et al, 2018 ; Meng et al, 2020 ; Trzcińska et al, 2020 ). For example, Trzcińska et al (2020) .…”
Section: Topical Applications Of Antimicrobial Peptides For Bone Tiss...mentioning
confidence: 99%
See 1 more Smart Citation
“…This polymerised layer has numerous catechol groups allowing the covalent attachment of thiol or amine groups [ 35 ]. This simple and versatile coating method has been used to attach antimicrobial peptides to a variety of biomaterial surfaces, including titanium, glass, plastics, polymers, gauze and stainless steel [ 36 , 37 , 38 ]. Covalently attaching peptidomimetics using dopamine-functionalised surfaces has significant potential for these coatings to be applied clinically to medical devices.…”
Section: Introductionmentioning
confidence: 99%